| Latest Omrix Biopharmaceuticals News Headlines | | Date | Time | Source | | | 09/18/2007 | 8:00AM | PRNUS | Peptimmune Appoints Fredric Price as Chairman and Reorganizes its Board of Directors
CAMBRIDGE, Mass., Sept. 18 /PRNewswire/ -- Peptimmune, Inc. a privately held biotechnology company, announced that Fredric D. Price has been appointed Executive Chairman of the Board of Directors. Mr. Price brings more than 30 years of biotechnology and pharmaceuticals industry experience to the company, including... More...>> |
| 07/05/2006 | 8:30AM | PRNUS | Symphony Medical Announces Initiation of Phase II Multi-Center Clinical Trial for Biologic Therapy to Prevent Post-Operative At Study Intended to Validate Efficacy and Move Novel Technology Closer to Commercialization
LAGUNA HILLS, Calif., July 5 /PRNewswire/ -- Symphony Medical, Inc., a developer of new non-destructive biologic and biopolymer therapies to treat atrial fibrillation and other cardiac abnormalities, announced today patient enrollment... More...>> |
|